Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The *joining chain of multimeric IgA and IgM pseudogene 1* (JCHAINP1) is a recognized human pseudogene that shares sequence similarity to the functional immunoglobulin J chain gene (IGJ), which encodes the J chain responsible for joining monomers of IgA and IgM antibodies into polymeric forms[1][2][7]. Unlike the functional IGJ gene, JCHAINP1 does not encode a protein and is not known to be transcribed or translated in normal biology. Pseudogenes such as JCHAINP1 result from gene duplication or retrotransposition and often contain disruptive mutations that prevent their expression or function[4]. There are no known biological functions, disease associations, or drug interactions specific to this pseudogene. If a functional target related to immunoglobulin multimerization is desired, the correct entity is the IGJ gene (joining chain of multimeric IgA and IgM)[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on joining chain of multimeric IgA and IgM pseudogene 1 (JCHAINP1).